Literature DB >> 15282265

Genetic variants of the human H+/dipeptide transporter PEPT2: analysis of haplotype functions.

Julia Pinsonneault1, Carsten Uhd Nielsen, Wolfgang Sadée.   

Abstract

PEPT2 is a high-affinity H+/dipeptide transporter expressed in kidney, brain, lung, and mammary gland. The physiological role of PEPT2 in kidney is to reabsorb small peptides generated by luminal peptidases. PEPT2 is also a transporter for peptide-like drugs such as penicillins and cephalosporins. We have conducted a haplotype analysis of 27 single nucleotide polymorphisms located in or near exons of the human gene encoding hPEPT2 (SLC15A2), using genotyping data from 247 genomic DNA samples from the Coriell collection. Our analysis reveals that hPEPT2 has a >6-kilobase sequence block with at least 10 abundant polymorphisms in almost complete linkage disequilibrium. As a result, only two main hPEPT2 variants exist (hPEPT2*1 and *2) with several phased amino acid substitutions, present in substantial frequencies in all ethnic groups tested. When expressed in Chinese hamster ovary cells, hPEPT2*1 and *2 displayed similar Vmax values for glycyl-sarcosine (Gly-Sar), but they differed significantly in their Km values (83 +/- 16 and 233 +/- 38 microM, respectively). Moreover, hPEPT2*1 and *2 differed in their pH sensitivity for H+/Gly-Sar transport. In addition, hPEPT2*1 and *2 generated varying levels of mRNA in nine heterozygous kidney tissue samples, including one allele expressing no detectable mRNA, suggesting the presence of cis-acting polymorphisms affecting transcription or mRNA processing. The results indicate that polymorphisms in the gene encoding hPEPT2 can alter substrate transport and therefore could affect drug disposition in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15282265     DOI: 10.1124/jpet.104.073098

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  36 in total

1.  CYP2C9 promoter variable number tandem repeat polymorphism regulates mRNA expression in human livers.

Authors:  Danxin Wang; Xiaochun Sun; Yan Gong; Brian E Gawronski; Taimour Y Langaee; Mohamed Hossam A Shahin; Sherief I Khalifa; Julie A Johnson
Journal:  Drug Metab Dispos       Date:  2012-01-30       Impact factor: 3.922

2.  hPEPT1 is responsible for uptake and transport of Gly-Sar in the human bronchial airway epithelial cell-line Calu-3.

Authors:  Helle Bach Søndergaard; Birger Brodin; Carsten Uhd Nielsen
Journal:  Pflugers Arch       Date:  2007-12-20       Impact factor: 3.657

3.  Polymorphisms affecting gene transcription and mRNA processing in pharmacogenetic candidate genes: detection through allelic expression imbalance in human target tissues.

Authors:  Andrew D Johnson; Ying Zhang; Audrey C Papp; Julia K Pinsonneault; Jeong-Eun Lim; David Saffen; Zunyan Dai; Danxin Wang; Wolfgang Sadée
Journal:  Pharmacogenet Genomics       Date:  2008-09       Impact factor: 2.089

4.  Influence of peptide transporter 2 (PEPT2) on the distribution of cefadroxil in mouse brain: A microdialysis study.

Authors:  Xiaomei Chen; Richard F Keep; Yan Liang; Hao-Jie Zhu; Margareta Hammarlund-Udenaes; Yongjun Hu; David E Smith
Journal:  Biochem Pharmacol       Date:  2017-02-10       Impact factor: 5.858

5.  Regulatory polymorphisms in CYP2C19 affecting hepatic expression.

Authors:  Jonathan C Sanford; Yingying Guo; Wolfgang Sadee; Danxin Wang
Journal:  Drug Metabol Drug Interact       Date:  2013

6.  Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs.

Authors:  D Wang; Y Guo; S A Wrighton; G E Cooke; W Sadee
Journal:  Pharmacogenomics J       Date:  2010-04-13       Impact factor: 3.550

7.  Evidence for extensive pleiotropy among pharmacogenes.

Authors:  Matthew T Oetjens; William S Bush; Joshua C Denny; Kelly Birdwell; Nuri Kodaman; Anurag Verma; Holli H Dilks; Sarah A Pendergrass; Marylyn D Ritchie; Dana C Crawford
Journal:  Pharmacogenomics       Date:  2016-06-01       Impact factor: 2.533

Review 8.  The pharmacogenomics of membrane transporters project: research at the interface of genomics and transporter pharmacology.

Authors:  D L Kroetz; S W Yee; K M Giacomini
Journal:  Clin Pharmacol Ther       Date:  2009-11-25       Impact factor: 6.875

9.  Interethnic differences of PEPT2 (SLC15A2) polymorphism distribution and associations with cephalexin pharmacokinetics in healthy Asian subjects.

Authors:  Rui Liu; Audrey May Yi Tang; Yen Ling Tan; Lie Michael George Limenta; Edmund Jon Deoon Lee
Journal:  Eur J Clin Pharmacol       Date:  2008-09-03       Impact factor: 2.953

Review 10.  Role and relevance of PEPT2 in drug disposition, dynamics, and toxicity.

Authors:  Mohamed A Kamal; Richard F Keep; David E Smith
Journal:  Drug Metab Pharmacokinet       Date:  2008       Impact factor: 3.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.